Atossa Genetics to Present at Two Upcoming Investor Conferences
January 09, 2014 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jan 9, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that management will present at two upcoming investor conferences:...
Atossa Genetics Acquires Rights to Patents Covering a Novel Screening Test for Breast Cancer From the Dr. Susan Love Research Foundation
July 13, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jul 13, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Completes $6.6 Million Over-Subscribed Private Placement
June 27, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jun 27, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Announces Licensing of Its New National Reference Laboratory for Breast Health
May 24, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 24, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. and HLB, LLC Announce Partnership to Manufacture Atossa's Patented, FDA-Cleared MASCT System for Breast Cancer Risk Assessment
May 03, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA and CHICAGO, IL--(Marketwire - May 3, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular...
Steven C. Quay, M.D., Ph.D., of Atossa Genetics Elected as a Fellow of the College of American Pathologists
March 14, 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Seattle Business Magazine Recognizes Steven C. Quay, M.D., Ph.D., of Atossa Genetics, Inc., as One of the Pacific Northwest's Top Leaders in Health Care
March 04, 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 4, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
October 01, 2010 09:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Appoints Robert L. Kelly as President
May 25, 2010 09:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 25, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
February 25, 2010 11:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - February 25, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...